These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31342394)

  • 21. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.
    Manca G; Tardelli E; Rubello D; Gennaro M; Marzola MC; Cook GJ; Volterrani D
    Nucl Med Commun; 2016 Jun; 37(6):570-6. PubMed ID: 26886421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Ersoy YE; Kadioglu H
    Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?].
    Coutant C; Jankowski C; Portha H; Barranger E
    Gynecol Obstet Fertil; 2016 Jun; 44(6):345-9. PubMed ID: 27234216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.
    Garcia-Tejedor A; Falo C; Quetglas C; Soler T; Marqueta B; Ortega R; Gil-Gil M; Pernas S; Fernandez-Montolí E; Pla MJ; Guma A; Bajen M; Benitez A; Eraso A; Campos M; Petit A; Ponce J
    Int J Surg; 2017 Mar; 39():141-147. PubMed ID: 28153783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Axillary Evaluation Using Reflector-Guided Sentinel Lymph Node Biopsy: A Prospective Feasibility Study and Comparison With Conventional Lymphatic Mapping Techniques.
    Taback B; Jadeja P; Ha R
    Clin Breast Cancer; 2018 Oct; 18(5):e869-e874. PubMed ID: 29544701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain.
    Munoz P; Corral S; Martínez-Regueira F; Paz A; Muñoz-Madero V; Mena A; Cabañas J; Rivas S
    Clin Transl Oncol; 2023 May; 25(5):1463-1471. PubMed ID: 36586064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
    Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
    BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
    Sun J; Henry DA; Carr MJ; Yazdankhahkenary A; Laronga C; Lee MC; Hoover SJ; Sun W; Czerniecki BJ; Khakpour N; Kiluk JV
    Clin Breast Cancer; 2021 Jun; 21(3):e189-e193. PubMed ID: 32893094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ongoing clinical trials on axillary management.
    Kouloura A; Lanitis S; Filopoulos E; Angelopoulos MP; Kosmidis SP; Arkadopoulos N
    Minerva Chir; 2020 Dec; 75(6):408-418. PubMed ID: 33345527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - recommendations for clinical guidance.
    Fontein DB; van de Water W; Mieog JS; Liefers GJ; van de Velde CJ
    Eur J Surg Oncol; 2013 May; 39(5):417-24. PubMed ID: 23473972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis.
    Keelan S; Boland MR; Ryan ÉJ; Moran LR; Davey MG; Lloyd AJ; Elwahab S; Hill ADK
    Br J Surg; 2023 Feb; 110(3):324-332. PubMed ID: 36512473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.
    Wu S; Wang Y; Zhang N; Li J; Xu X; Shen J; Liu G
    Ann Surg Oncol; 2018 Oct; 25(11):3150-3157. PubMed ID: 30083833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node biopsy following neoadjuvant chemotherapy: an evidence-based review and recommendations for current practice.
    Cavalcante FP; Millen EC; Novita GG; Zerwes FP; Mattar A; Machado RHS; Frasson AL
    Chin Clin Oncol; 2023 Feb; 12(1):6. PubMed ID: 36922355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.
    Wong SM; Weiss A; Mittendorf EA; King TA; Golshan M
    Ann Surg Oncol; 2019 Oct; 26(11):3517-3525. PubMed ID: 31342389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.
    Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS
    Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.